BlackRock Health Ownership

BMEZ Stock  USD 15.66  0.10  0.64%   
BlackRock Health holds a total of 103.85 Million outstanding shares. Almost 73.51 percent of BlackRock Health outstanding shares are held by general public with 0.01 (percent) owned by insiders and only 26.48 % by other corporate entities. On February 24, 2020, Senator John Hoeven of US Senate acquired $100k to $250k worth of BlackRock Health Sciences's common stock.
Some institutional investors establish a significant position in stocks such as BlackRock Health in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of BlackRock Health, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Dividends Paid is likely to drop to about 71.7 M in 2024. Common Stock Shares Outstanding is likely to drop to about 115 M in 2024.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BlackRock Health Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

BlackRock Stock Ownership Analysis

About 26.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.87. Some equities with similar Price to Book (P/B) outperform the market in the long run. BlackRock Health Sciences recorded a loss per share of 0.16. The entity last dividend was issued on the 31st of March 2023. For more info on BlackRock Health Sciences please contact the company at 212 810 5300.
Besides selling stocks to institutional investors, BlackRock Health also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different BlackRock Health's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align BlackRock Health's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

BlackRock Health Quarterly Liabilities And Stockholders Equity

3.09 Billion

BlackRock Health Insider Trades History

Less than 1% of BlackRock Health Sciences are currently held by insiders. Unlike BlackRock Health's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against BlackRock Health's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of BlackRock Health's insider trades
 
Covid

BlackRock Health Sciences Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific BlackRock Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on BlackRock Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases BlackRock Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Saba Capital Management, L.p. over a month ago
Acquisition by Saba Capital Management, L.p. of 15281 shares of BlackRock Health at 15.87 subject to Rule 16b-3
 
Wasserman Aaron David over two months ago
Insider Trading
 
Saba Capital Management, L.p. over two months ago
Acquisition by Saba Capital Management, L.p. of 20534 shares of BlackRock Health at 15.88 subject to Rule 16b-3
 
Saba Capital Management, L.p. over three months ago
Acquisition by Saba Capital Management, L.p. of 129372 shares of BlackRock Health at 16.32 subject to Rule 16b-3
 
Saba Capital Management, L.p. over three months ago
Acquisition by Saba Capital Management, L.p. of 124233 shares of BlackRock Health at 13.8 subject to Rule 16b-3
 
Saba Capital Management, L.p. over three months ago
Acquisition by Saba Capital Management, L.p. of 50471 shares of BlackRock Health at 13.79 subject to Rule 16b-3
 
Saba Capital Management, L.p. over six months ago
Acquisition by Saba Capital Management, L.p. of 159907 shares of BlackRock Health at 14.42 subject to Rule 16b-3
 
Saba Capital Management, L.p. over six months ago
Acquisition by Saba Capital Management, L.p. of 16297 shares of BlackRock Health at 16.33 subject to Rule 16b-3
 
Saba Capital Management, L.p. over six months ago
Acquisition by Saba Capital Management, L.p. of 129372 shares of BlackRock Health at 16.32 subject to Rule 16b-3
 
Saba Capital Management Lp over six months ago
Purchase by Saba Capital Management Lp of 46958 shares of BlackRock Health
 
Saba Capital Management, L.p. over six months ago
Acquisition by Saba Capital Management, L.p. of 46958 shares of BlackRock Health at 16.3 subject to Rule 16b-3
 
Saba Capital Management, L.p. over six months ago
Acquisition by Saba Capital Management, L.p. of 41300 shares of BlackRock Health at 16.46 subject to Rule 16b-3

BlackRock Health's latest congressional trading

Congressional trading in companies like BlackRock Health Sciences, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in BlackRock Health by those in governmental positions are based on the same information available to the general public.
2020-02-24Senator John HoevenAcquired $100K to $250KVerify

BlackRock Health Outstanding Bonds

BlackRock Health issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. BlackRock Health Sciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most BlackRock bonds can be classified according to their maturity, which is the date when BlackRock Health Sciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

BlackRock Health Corporate Filings

26th of November 2024
Other Reports
ViewVerify
20th of November 2024
Other Reports
ViewVerify
F4
17th of October 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
16th of October 2024
Other Reports
ViewVerify

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for BlackRock Stock Analysis

When running BlackRock Health's price analysis, check to measure BlackRock Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BlackRock Health is operating at the current time. Most of BlackRock Health's value examination focuses on studying past and present price action to predict the probability of BlackRock Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BlackRock Health's price. Additionally, you may evaluate how the addition of BlackRock Health to your portfolios can decrease your overall portfolio volatility.